Effect of selenium in treatment of gestational diabetes
Phase 2
- Conditions
- O24.9Gestational diabetes mellitus.Diabetes mellitus in pregnancy, unspecified
- Registration Number
- IRCT201403175623N18
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Pregnant women aged 18-40 years
Pregnant women diagnosed with gestational diabetes mellitus
24-28 weeks' gestation
Exclusion Criteria
Intrauterine fetal death
Premature preterm rupture of membrane
Placenta abruption
Preeclampsia
Eclampsia
Chronic hypertension
Hypo- or hyperthyroidism
Urinary tract infection
Smokers
Kidney or liver diseases
Those taking estrogen therapy
Stressful life conditions
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance. Timepoint: Baseline and End-of-trial. Method of measurement: Calculation using HOMA formula.
- Secondary Outcome Measures
Name Time Method